Peptides for Therapy and Diagnosis of Alzheimer's Disease

被引：2

作者：

Funke, Susanne Aileen ^{[1
]}

Willbold, Dieter ^{[1
,2
]}

机构：

[1] Forschungszentrum Julich, D-52425 Julich, Germany

[2] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany

来源：

CURRENT PHARMACEUTICAL DESIGN | 2012年 / 18卷 / 06期

关键词：

Alzheimer's disease; amyloid-beta; therapy; diagnosis; peptides; AMYLOID-BETA-PEPTIDE; IMAGE PHAGE DISPLAY; I MIMETIC PEPTIDES; FIBRIL FORMATION; MOUSE MODEL; APOLIPOPROTEIN-E; TAU HYPERPHOSPHORYLATION; NEUROFIBRILLARY TANGLES; COGNITIVE FUNCTION; LEARNING-DEFICITS;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with devastating effects. The greatest risk factor to develop AD is age. Today, only symptomatic therapies are available. Additionally, AD can be diagnosed with certainty only post mortem, whereas the diagnosis "probable AD" can be established earliest when severe clinical symptoms appear. Specific neuropathological changes like neurofibrillary tangles and amyloid plaques define AD. Amyloid plaques are mainly composed of the amyloid-beta peptide (A beta). Several lines of evidence suggest that the progressive concentration and subsequent aggregation and accumulation of A beta play a fundamental role in the disease progress. Therefore, substances which bind to A beta and influence aggregation thereof are of great interest. An enormous number of organic substances for therapeutic purposes are described. This review focuses on peptides developed for diagnosis and therapy of AD and discusses the pre- and disadvantages of peptide drugs.

引用

页码：755 / 767

页数：13

共 137 条

[21] Opportunities and Challenges of Developing Peptide Drugs in the Pharmaceutical Industry [J].

Danho, Waleed ;

Swistok, Joseph ;

Khan, Wajiha ;

Chu, Xin-Jie ;

Cheung, Adrian ;

Fry, David ;

Sun, Hongmao ;

Kurylko, Grazyna ;

Rumennik, Leonid ;

Cefalu, Joseph ;

Cefalu, Gretchen ;

Nunn, Philip .

PEPTIDES FOR YOUTH: THE PROCEEDINGS OF THE 20TH AMERICAN PEPTIDE SYMPOSIUM, 2009, 611 :467-469

[22] In vitro model of neurotoxicity of Aβ 1-42 and neuroprotection by a pentapeptide:: irreversible events during the first hour [J].

Datki, Z ;

Papp, R ;

Zádori, D ;

Soós, K ;

Fülöp, L ;

Juhász, A ;

Laskay, G ;

Hetényi, C ;

Mihalik, E ;

Zarándi, M ;

Penke, B .

NEUROBIOLOGY OF DISEASE, 2004, 17 (03) :507-515

[23] Inhibition of toxicity and protofibril formation in the amyloid-β peptide β(25-35) using N-methylated derivatives [J].

Doig, AJ ;

Hughes, E ;

Burke, RM ;

Su, TJ ;

Heenan, RK ;

Lu, J .

BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 :537-542

[24] Systematic review of the diagnostic accuracy of 99mTc-HWAO-SPECT in dementia [J].

Dougall, NJ ;

Bruggink, S ;

Ebmeier, KP .

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 12 (06) :554-570

[25] EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers [J].

Ehrnhoefer, Dagmar E. ;

Bieschke, Jan ;

Boeddrich, Annett ;

Herbst, Martin ;

Masino, Laura ;

Lurz, Rudi ;

Engemann, Sabine ;

Pastore, Annalisa ;

Wanker, Erich E. .

NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2008, 15 (06) :558-566

[26] Disrupting β-amyloid aggregation for Alzheimer disease treatment [J].

Estrada, L. D. ;

Soto, C. .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (01) :115-126

[27] Stoichiometric inhibition of amyloid β-protein aggregation with peptides containing alternating α,α-disubstituted amino acids [J].

Etienne, MA ;

Aucoin, JP ;

Fu, YW ;

McCarley, RL ;

Hammer, RP .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (11) :3522-3523

[28]

Fauchere J.-L., 1992, ADV DRUG RES, V23, P127

[29] A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1 [J].

Fielding, PE ;

Nagao, K ;

Hakamata, H ;

Chimini, G ;

Fielding, CJ .

BIOCHEMISTRY, 2000, 39 (46) :14113-14120

[30] Modified-peptide inhibitors of amyloid β-peptide polymerization [J].

Findeis, MA ;

Musso, GM ;

Arico-Muendel, CC ;

Benjamin, HW ;

Hundal, AM ;

Lee, JJ ;

Chin, J ;

Kelley, M ;

Wakefield, J ;

Hayward, NJ ;

Molineaux, SM .

BIOCHEMISTRY, 1999, 38 (21) :6791-6800

← 1 2 3 4 5 6 7 8 9 10 →